The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Gowing L, Ali R, Dunlop A, et al. National guidelines for medication‐assisted treatment of opioid dependence. Canberra: Commonwealth of Australia 2014. https://www.health.gov.au/resources/publications/national‐guidelines‐for‐medication‐assisted‐treatment‐of‐opioid‐dependence (viewed Mar 2021).
- 2. Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs 2003; 35: 253–259.
- 3. Trafkowski J, Madea B, Musshoff F. The significance of putative urinary markers of illicit heroin use after consumption of poppy seed products. Ther Drug Monit 2006; 28: 552–558.
- 4. Braye K, Harwood T, Inder R, et al. Poppy seed tea and opiate abuse in New Zealand. Drug Alcohol Rev 2007; 26: 215–219.
- 5. Lloyd‐Jones D, Bonomo Y. Unusual presentations for pharmacotherapy – poppy seed dependence. Drug Alcohol Rev 2006; 25: 375–376.
- 6. Kirolos H. Modern poppy seed tea: an un‐healthy recipe. Proc UCLA Healthc 2017; 21; https://www.proceedings.med.ucla.edu/wp‐content/uploads/2018/01/A170918HK‐1‐WH‐edited.pdf (viewed Mar 2021).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
We acknowledge the contributions of Keri Alexander and Stephanie Dias to the treatment provided.
Shalini Arunogiri has received speaker honoraria from Gilead, Janssen‐Cilag and Camurus. Dan Lubman has provided consultancy advice to Lundbeck and Indivior, has received travel support and speaker honoraria from AstraZeneca, Janssen, Lundbeck, Shire and Servier, and has been an investigator on an untied education grant from Sequirus. All of the above payments and services are unrelated to the present article.